The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2019

Filed:

Nov. 25, 2016
Applicant:

Mitsubishi Tanabe Pharma Corporation, Osaka-shi, Osaka, JP;

Inventors:

Atsushi Sato, Osaka, JP;

Ritsuo Imashiro, Osaka, JP;

Hidekazu Tsujishima, Osaka, JP;

Kouichi Tanimoto, Osaka, JP;

Yasuo Yamamoto, Osaka, JP;

Tetsu Nakane, Osaka, JP;

Chihiro Toshikawa, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4168 (2006.01); C07D 233/88 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); A61K 31/454 (2006.01); A61K 31/4725 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); C07D 403/14 (2006.01); C07D 417/14 (2006.01); A61P 17/06 (2006.01); A61P 37/02 (2006.01); A61P 13/12 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 31/454 (2013.01); A61K 31/4725 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61P 13/12 (2018.01); A61P 17/06 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 37/02 (2018.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01);
Abstract

The present invention relates to a novel imidazole compound or a pharmaceutically acceptable salt thereof having a melanocortin receptor agonistic activity, and medical use thereof. The present invention relates to an imidazole compound represented by general formula [I] [wherein: Ring A represents an optionally substituted aryl group or the like; Rrepresents a hydrogen atom, an optionally substituted alkyl group, or the like; Rrepresents a hydrogen atom, a halogen atom, or the like; and Rrepresents an optionally substituted alkyl group] or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…